Study about the results of the addition of a sulfonylurea, DPP4 inhibitors or SGLT2 inhibitors as a second antidiabetic drug in patients with diabetes mellitus type 2 in treatment with metformin and insufficient glycemic control. (eControl Met +) First published 05/05/2018 Last updated 14/03/2024 EU PAS number:EUPAS23769 Study Planned
